Assessment of the Results of Inovo Sense Smile and Inovo Sense Style Filler Injections to Correction Nasolabial Folds
Phase 2
- Conditions
- Skin aging.
- Registration Number
- IRCT20220723055530N1
- Lead Sponsor
- Khosro Medisa Teb Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
30 -65 Years old men and women with moderate to severe nasolabial folds
Signing the informed consent form
Exclusion Criteria
History of a cosmetic procedure in the lower 2/3 of the face during the last three months
Previous allergy to Hyaluronic Acid or Lidocaine
Presence of inflammation, active infection, unhealed old wound, and skin lesions in the NLF region
People prone to hypertrophic scar formation
History of autoimmune or immune deficiency diseases
Pregnancy or breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of nasolabial folds. Timepoint: Before intervention, immediately after that, 2 weeks, and 3 months later. Method of measurement: 5-point photonumeric Allergan scale.
- Secondary Outcome Measures
Name Time Method Depth, area and volume of nasolabial folds. Timepoint: Before the intervention, immediately after that, 2 weeks, and 3 months later. Method of measurement: Visioface camera.